Q

Qiagen NV
D

QGEN

47.550
USD
0.51
(1.08%)
مغلق
حجم التداول
28,366
الربح لكل سهم
2
العائد الربحي
0.53
P/E
28
حجم السوق
10,310,469,491
أصول ذات صلة
NEOUSD
NEOUSD
-0.03771
(-0.58%)
6.48211 USD
BDX
BDX
1.210
(0.63%)
192.620 USD
C
CRL
1.630
(1.00%)
163.930 USD
DGX
DGX
3.314
(1.84%)
183.459 USD
GILD
GILD
1.270
(1.13%)
114.020 USD
HOLX
HOLX
0.375
(0.56%)
66.765 USD
IQV
IQV
2.710
(1.47%)
186.780 USD
LH
LH
3.56
(1.29%)
278.62 USD
N
NEO
-0.07000
(-0.87%)
7.99000 USD
TMO
TMO
3.14
(0.64%)
501.22 USD
المزيد
الأخبار المقالات

العنوان: Qiagen N.V.

القطاع: Healthcare
الصناعة: Diagnostics & Research
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).